In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor
Science Advances · 18.04.2025 · 11 (16)
DOI: 10.1126/sciadv.ads0265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 18.04.2025. Verfasst von Martina Corsi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Information Engineering, University of Pisa, via G. Caruso 16, 56122 Pisa, Italy. Hauptthemen laut MEDLINE: Doxorubicin, Biosensing Techniques, Absorbable Implants, Drug Monitoring. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer treatment, particularly chemotherapy, requires balancing efficacy and toxicity. Although traditional monitoring methods can lead to suboptimal outcomes, emerging implantable chemical sensors can complement them by providing precise, real-time drug monitoring at tumor sites, although the technology remains in its early stages. Here, we introduce an ultrathin, bioresorbable implantable biosensor for real-time doxorubicin monitoring in vivo with high spatiotemporal resolution. The sensor amplifies the drug’s fluorescence, enabling successful tracking of doxorubicin through the skin in live mice following intravenous injection. When paired with a reusable electronic patch, the biosensor facilitates seamless data collection and wireless transmission. A 3-month biocompatibility study, including systemic toxicity assessments, histological and blood analyses, confirms complete biodegradation with no observed toxicity. By directly measuring chemotherapeutic drug levels in tissues over time, our sensor enhances traditional monitoring methods, enabling clinicians to optimize dosing during cancer treatment and reduce the risk of locoregional recurrence following tumor removal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Information Engineering, University of Pisa, via G. Caruso 16, 56122 Pisa, Italy.
- Department of Biomedical Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via G. Campi 287, 41125 Modena, Italy.
- Department of Medical and Surgical Science for Children and Adults, University Hospital of Modena and Reggio Emilia, Via del Pozzo, 71, 41124 Modena, Italy.
- Department of Translational Research and New Technologies in Medicine and Surgery School of Medicine, University of Pisa, Via Risorgimento 36, 56126 Pisa, Italy.
ORCID-Profile: Martina Corsi, Elena Maurina, Salvatore Surdo, Eleonora Daini, Giuseppina Leo, Moein Farshchian, Giulia Grisendi, Giulia Golinelli, Guido Bocci, Daniela Giuliani, Giuseppe Barillaro
Zitieren
APA
Corsi, M., Maurina, E., Surdo, S., Vandini, E., Daini, E., Vilella, A., Leo, G., Farshchian, M., Grisendi, G., Golinelli, G., Dominici, M., Bocci, G., Giuliani, D., & Barillaro, G. (2025). In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor. Science Advances, 11(16). https://doi.org/10.1126/sciadv.ads0265
Vancouver
Corsi M, Maurina E, Surdo S, Vandini E, Daini E, Vilella A, et al. In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor. Science Advances. 2025;11(16). doi:10.1126/sciadv.ads0265
BibTeX
@article{Corsi2025,
author = {Corsi, Martina and Maurina, Elena and Surdo, Salvatore and Vandini, Eleonora and Daini, Eleonora and Vilella, Antonietta and Leo, Giuseppina and Farshchian, Moein and Grisendi, Giulia and Golinelli, Giulia and Dominici, Massimo and Bocci, Guido and Giuliani, Daniela and Barillaro, Giuseppe},
title = {In vivo and in situ monitoring of doxorubicin pharmacokinetics with an implantable bioresorbable optical sensor},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {16},
doi = {10.1126/sciadv.ads0265}
}
EUVIMED